What is CROMSOURCE?
Founded in 1994 and headquartered in Waltham, Massachusetts, CROMSOURCE operates as an ISO-certified contract research organization (CRO). The company offers a comprehensive suite of services tailored to the needs of the pharmaceutical, biotechnology, and medical device industries. Its commitment to quality and regulatory compliance is evidenced by its ISO certification, positioning it as a reliable partner for clinical research and development.
How much funding has CROMSOURCE raised?
CROMSOURCE has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in CROMSOURCE
PPP
Public-Private Partnership
What's next for CROMSOURCE?
The recent major strategic investment signals a pivotal phase for CROMSOURCE, likely enabling expansion of its service offerings, enhancement of its technological infrastructure, or broader market penetration. As an established player in the CRO landscape, this financing will empower the company to further support its clients in bringing innovative therapies and medical devices to market, potentially through increased clinical trial capacity or the development of specialized research capabilities. The enterprise-level funding suggests a focus on scaling operations and solidifying its competitive advantage.
See full CROMSOURCE company page
